Darin Feinstein - 23 Jan 2024 Form 4 Insider Report for Core Scientific, Inc./tx (CORZ)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Jan 2024, 21:15:30 UTC
Prior SEC filing
06 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Todd DuChene, as Attorney-in-Fact

Key filing fact

Darin Feinstein filed Form 4 for Core Scientific, Inc./tx (CORZ) on 25 Jan 2024.

Key facts

  • This page summarizes Darin Feinstein's Form 4 filing for Core Scientific, Inc./tx (CORZ).
  • 7 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Jan 2024, 21:15.

Change

  • Previous filing in this sequence was filed on 06 Jun 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORZ transaction

Common Stock, par value $0.0001 per share

Disposed to Issuer

Transaction value
Shares
-30,483,592
Change %
-100%
Price
Shares after
0
Date
23 Jan 2024
Ownership
Direct
Footnotes
F1, F2
CORZ transaction

Common Stock, par value $0.0001 per share

Disposed to Issuer

Transaction value
Shares
-319,894
Change %
-100%
Price
Shares after
0
Date
23 Jan 2024
Ownership
See Footnote
Footnotes
F1, F2, F4
CORZ transaction

Common Stock, par value $0.0001 per share

Disposed to Issuer

Transaction value
Shares
-974,301
Change %
-100%
Price
Shares after
0
Date
23 Jan 2024
Ownership
See Footnote
Footnotes
F1, F2, F5
CORZ transaction

Common Stock, par value $0.00001 per share

Award

Transaction value
Shares
+30,483,592
Change %
Price
Shares after
30,483,592
Date
23 Jan 2024
Ownership
Direct
Footnotes
F2
CORZ transaction

Common Stock, par value $0.00001 per share

Award

Transaction value
Shares
+853,577
Change %
+2.8%
Price
Shares after
31,337,169
Date
23 Jan 2024
Ownership
Direct
Footnotes
F3
CORZ transaction

Common Stock, par value $0.00001 per share

Award

Transaction value
Shares
+319,894
Change %
Price
Shares after
319,894
Date
23 Jan 2024
Ownership
See Footnote
Footnotes
F2, F4
CORZ transaction

Common Stock, par value $0.00001 per share

Award

Transaction value
Shares
+974,301
Change %
Price
Shares after
974,301
Date
23 Jan 2024
Ownership
See Footnote
Footnotes
F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Darin Feinstein is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

On December 21, 2022, Core Scientific, Inc. (the "Issuer") and certain of its affiliates (collectively, the "Debtors") filed voluntary petitions (the "Chapter 11 Cases") in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court") seeking relief under Chapter 11 of Title 11 of the United States Code. On January 16, 2024, the Bankruptcy Court entered an order confirming the Debtors' Fourth Amended Joint Chapter 11 Plan of Reorganization of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) (the "Plan"), dated as of January 15, 2024. On January 23, 2024 (the "Effective Date"), the Plan became effective in accordance with its terms and the Debtors emerged from the Chapter 11 Cases.

Footnote F2

On the Effective Date, pursuant to the terms of the Plan, the Issuer's common stock outstanding immediately before the Effective Date, par value $0.0001 per share (the "Old Common Stock"), was canceled and is of no further force or effect, and in exchange all holders of Old Common Stock received their pro rata share of new common stock, par value $0.00001 per share ("New Common Stock") representing, in the aggregate, approximately 21% of the shares of the reorganized Issuer (subject to dilution by awards issuable under a new management incentive plan and shares of New Common Stock issuable upon conversion or exercise of certain secured convertible notes, warrants, contingent value rights and settlement shares issued as part of the reorganization). The receipt of the New Common Stock in exchange for Old Common Stock was involuntary, without consideration and in accordance with the Plan approved by the Bankruptcy Court.

Footnote F3

In accordance with the Plan, holders of the Issuer's Old Common Stock as of November 16, 2023 were granted the right to participate in a rights offering (the "Rights Offering") for the purchase, on a pro rata basis, of up to $55 million of New Common Stock to be issued pursuant to the Plan. In addition, certain members of the Issuer's board of directors and management, including the Reporting Person, committed to purchase a portion of any New Common Stock not otherwise subscribed for in the Rights Offering pursuant to a backstop commitment letter (the "Backstop Commitment Letter"). The Reporting Person purchased 796,672 shares of New Common Stock pursuant to the Rights Offering. The Reporting Person did not purchase any New Common Stock under the Backstop Commitment Letter, but received a commitment premium of 56,905 shares of New Common Stock as consideration for entering into the Backstop Commitment Letter.

Footnote F4

The shares are held by Red Moon 88, LLC, which the Reporting Person serves as its managing member.

Footnote F5

The shares are held by Texas Blockchain 888, LLC, which the Reporting Person serves as its managing member.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .